Using exosomes to reduce brain inflammation
Official title: Mitochondrial-targeting Exosomes for Neuroinflammation
Funded at Michigan Technological University · NIH-10875884 · Data updated 2026-11-12
This study is looking at how tiny particles called exosomes can help reduce inflammation in the brain, which could be beneficial for people with conditions like Alzheimer's and ALS, by delivering special molecules that target the problem directly.
Quick facts
| Grant type | R15 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Michigan Technological University NIH-funded |
| Lab location | 1 site (Houghton, United States) |
| Project start | August 1, 2024 |
| Project end | July 31, 2027 |
| Funding year | 2024 |
| Award (this year) | $469,500 |
| NIH project number | 1R15EB035866-01 |
| Project ID | NIH-10875884 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals diagnosed with Alzheimer's disease, amyotrophic lateral sclerosis, or other neuroinflammatory conditions.
✕Less likely to help
Patients with neuroinflammatory disorders not related to mitochondrial dysfunction may not benefit from this research.
What this research studies
This research investigates how exosomes, which are tiny vesicles that can deliver therapeutic molecules, can be used to target and reduce neuroinflammation in the brain. The focus is on developing mitochondrial-targeting exosomes that carry anti-inflammatory microRNAs to treat conditions like Alzheimer's and amyotrophic lateral sclerosis. By overcoming the challenges posed by the blood-brain barrier, the study aims to restore mitochondrial function and reduce oxidative stress in affected neuronal populations. The research will involve testing these exosomes in animal models to evaluate their effectiveness in reducing neuroinflammation over time.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that significantly improve outcomes for patients with neuroinflammatory disorders.
How similar studies have gone: While the use of exosomes in treating neuroinflammation is a relatively novel approach, preliminary studies have shown promise in similar applications.
Where this research is happening
-
Michigan Technological University
Houghton, United States Active
Researchers
- Principal investigator: Bi, Lanrong — Michigan Technological University
- Study coordinator: Bi, Lanrong
Related research
Other NIH-funded projects on the same topics.
-
TinyML-powered closed-loop DBS for Parkinson's disease
A small, energy-efficient brain-stimulation system using lightweight AI runs on an implanted device to adapt DBS in real time for people with Parkinson's disease.
-
Understanding how metalloenzymes work and move
Scientists are studying metal-containing enzymes to learn how their metal centers and surrounding parts make them powerful in cells and how this knowledge could inform better medicines.
-
Developing a new way to make influenza vaccines more effectively.
This study is exploring a new way to make flu vaccines using cell technology instead of eggs, which could help create vaccines faster and make them work better, so people can get a more effective and affordable flu shot.
-
A new tool for studying cells and biomaterials at the nanoscale
This study is creating a special microscope that helps scientists see and measure tiny parts of cells and materials, making it easier to understand how they work, and it's designed to support researchers who want to learn how to use it.
-
How the orexin system affects high blood pressure
This study is looking at how a brain system called the orexin system affects high blood pressure that can be worsened by eating too much salt, and it's aimed at helping people with this condition find better ways to manage it.
-
Understanding how cells detect the stiffness of their environment
This study is looking at how cells feel the stiffness of their surroundings, which is important for how they grow and move, and it aims to learn more about the proteins involved in this process to help us understand diseases related to cell behavior.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.